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Two Cases of Dermatitis Herpetiformis Successfully 
Treated with Tetracycline and Niacinamide
Dear Editor,
Dermatitis herpetiformis (DH) is a chronic, poly-
morphic, pruritic autoimmune blistering skin disease 
characterized by subepidermal blisters, neutrophilic 
microabscesses, and granular IgA deposition within 
the dermal papillae. DH is classified as a cutaneous 
manifestation of coeliac disease, a type of gluten-sen-
sitive enteropathy (1). The treatment of DH includes 
dapsone and a gluten-free diet (GFD). Other thera-
pies should be considered in patients who are un-
able to tolerate dapsone, including sulfapyridine and 
glucocorticoids. Herein we present two cases of DH 
with good responses to tetracycline and niacinamide 
combination therapy. 
Case 1 was a 42-year-old man who was admit-
ted to our hospital with a 3-year history of recurrent 
pruritic papules and bullous lesions involving the 
trunk and upper limbs. On examination, the patient 
showed disseminated erythematous papules on the 
upper limbs and back as well as vesicles. Nikolsky’s 
sign for vesicles was negative (Figure 1, a-c). The 
results of routine blood examinations were within 
normal ranges. He did not have a history of chronic 
Figure 1. Clinical appearance before treatment (a, b, c) and after 2 weeks of treatment (d, e, f ) in case 1. Subepidermal blisters 
and accumulation of neutrophils at the papillary dermis of the involved skin. (g) (hematoxylin and eosin, ×400). Direct im-
munofluorescence revealed fibrillar deposition of IgA on the dermal papillae (h).
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diarrhea. The histologic examination showed subepi-
dermal blisters and accumulation of neutrophils at 
the papillary dermis of the involved ski. Direct immu-
nofluorescence revealed fibrillar deposition of IgA on 
the dermal papillae (Figure 1. g, h). 
Case 2 was a 34-year-old woman who had a his-
tory of skin rash and pruritic lesions predominantly 
involving the arms and legs, which had been present 
for 10 months. She had been treated with prednisone 
(30 mg daily) with improvement; however, the lesions 
reappeared when the prednisone was discontinued. 
She had a history of constipation. On physical exami-
nation, the skin lesions manifested as erythematous 
papules, vesicles, and scabs on the limbs (Figure 2. a-
c). She felt apparently pruritic. The histologic exami-
nation of the biopsy identified subepidermal blisters 
with a neutrophil infiltrate in the upper dermis. Direct 
immunofluorescence revealed granular deposition of 
IgA on the dermal papillae (Figure 2. e, f ). The results 
of routine blood examinations were within normal 
ranges, with the exception of elevated IgE concentra-
tion (222.5 ku/L (normal range, 0-100 ku/L)). 
The clinical manifestations and histologic and 
immunofluorescence examinations of the two cases 
confirmed the diagnosis of DH. The two patients were 
subsequently started on a strict GFD. At that time, 
dapsone was not available in the hospital. The pa-
tients were treated with oral tetracycline (500 mg four 
times daily) and nicotinamide (500 mg three times 
daily). The rash affecting case 1 resolved entirely in 2 
weeks. The patient discontinued the medications af-
ter 6 months, and occasionally presented with a few 
Figure 2. Clinical appearance before treatment (a, b) and after 1 month of treatment (c, d) in case 2. Subepidermal blis-
ters and neutrophil infiltration at the upper dermis (e) (hematoxylin and eosin, ×400). Direct immunofluorescence revealed 
granular deposition of IgA on the dermal papillae (f ). 
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pruritic papules and vesicles, but the lesions resolved 
within 1 week. The lesions affecting case 2 completely 
healed within 1 month. The patient continued taking 
those medications and no recurrence of the skin le-
sions occurred during 2 years of follow-up.
Dapsone is considered first-line therapy for pa-
tients with DH (2). Recent findings have shown dap-
sone and lower dosages of sulfasalazine combination 
therapy in DH are effective and well-tolerated (3). 
Alternative monotherapeutic agents in mild autoim-
mune bullous diseases such as DH include a tetra-
cycline group of antibiotics with niacinamide or its 
derivatives as well as sulfasalazine. Because dapsone 
is difficult to obtain in China except for patients with 
leprosy, we treated the patients with tetracycline and 
nicotinamide. To our knowledge, only a few cases of 
DH have been successfully treated with oral tetracy-
cline and niacinamide (2,4). One of the patients was 
also prescribed heparin (4). Tetracycline has anti-in-
flammatory properties due to the inhibition of me-
talloproteinase activity and mast cell activation (5). 
Nicotinamide is a potent modulator of several pro-
inflammatory cytokines. Nicotinamide can inhibit 
cytokine release (IL-1, IL-6, IL-8, and TNF-α) from im-
mune cells, inhibit chemotaxis and degranulation of 
immune cells, inhibit lymphocyte blast transforma-
tion, and suppress T-cell activity (6). The non-antibi-
otic properties of tetracycline in combination with 
nicotinamide may participate in inhibition of anti-
body formation, modulation of pro-inflammatory cy-
tokines, inflammatory cell accumulation, lymphocyte 
transformation, and T-cell activation.
In summary, we reported two typical cases of DH 
that were successfully treated with oral tetracycline 
and niacinamide, which completely healed the rash 
and relieved the symptoms within 1 month. The 
combination of tetracycline and nicotinamide can be 
recommended as a useful therapy for patients where 
dapsone is not available or for patients who do not 
tolerate dapsone.
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